”For example, Singapore General Hospital worked with Biobot Surgical to develop a robotic system that conducts prostate biopsies using a navigation platform to position a needle that can target tumour areas accurately.
The system - used in Singapore hospitals and in Australia and Europe - has performed prostate biopsies on more than 6,000 patients.
Biobot Surgical's chief executive Sim Kok Hwee is hoping to break into the China market next year with an upgraded robotic system that contains both diagnostic and treatment functions, including cryotherapy, which freezes and kills prostate cancer cells.
Click here for full article ->
Photo taken from: https://www.straitstimes.com/singapore/the-rise-of-local-medtech-start-ups